RXRX |
RECURSION PHARMACEUTICALS, INC. |
Aug 15, 2024 |
1 |
-$80K |
4 |
Aug 19, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Aug 13, 2024 |
6 |
-$15.6K |
4 |
Aug 15, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Jul 9, 2024 |
6 |
-$43.5K |
4 |
Jul 11, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Jun 13, 2024 |
6 |
-$104K |
4 |
Jun 17, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
May 15, 2024 |
1 |
-$120K |
4 |
May 17, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Apr 16, 2024 |
6 |
-$201K |
4 |
Apr 18, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Mar 12, 2024 |
6 |
-$371K |
4 |
Mar 14, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 15, 2024 |
1 |
-$89.1K |
4 |
Feb 16, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 13, 2024 |
7 |
-$341K |
4 |
Feb 15, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 9, 2024 |
4 |
-$25.3K |
4 |
Feb 13, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Jan 16, 2024 |
6 |
-$351K |
4 |
Jan 18, 2024 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Dec 12, 2023 |
6 |
-$208K |
4 |
Dec 14, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Nov 14, 2023 |
8 |
-$226K |
4 |
Nov 16, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Oct 10, 2023 |
6 |
-$182K |
4 |
Oct 12, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Sep 12, 2023 |
6 |
-$261K |
4 |
Sep 14, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Aug 15, 2023 |
7 |
-$331K |
4 |
Aug 17, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Jul 18, 2023 |
9 |
-$563K |
4 |
Jul 19, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Jun 13, 2023 |
6 |
-$334K |
4 |
Jun 15, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
May 15, 2023 |
1 |
-$26.7K |
4 |
May 17, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 15, 2023 |
1 |
-$10.6K |
4 |
Feb 17, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 1, 2023 |
4 |
-$22.8K |
4 |
Feb 3, 2023 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Nov 15, 2022 |
1 |
-$12.6K |
4 |
Nov 17, 2022 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Aug 15, 2022 |
1 |
-$13.8K |
4 |
Aug 17, 2022 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
May 16, 2022 |
1 |
-$6.06K |
4 |
May 18, 2022 |
Chief Financial Officer |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 4, 2022 |
3 |
-$7.73K |
4/A |
Apr 28, 2023 |
Chief Financial Officer |